OptimizeRx (OPRX) Change in Acquisitions & Divestments (2023)

OptimizeRx (OPRX) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $53.6 million in Q4 2023.

• For the quarter ending Q4 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $53.6 million; the trailing twelve-month figure through Dec 2023 stood at $218.7 million (changed N/A YoY), and the FY2023 full-year result was $218.7 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments rose to $53.6 million in Q4 2023, from $52.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $56.9 million in Q2 2023 to a low of $52.6 million in Q3 2023.